Metrics as of 10/17/2026, 08:23 AM (Berlin time), refresh in progress.
CareDx Stock
CareDx, Inc
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- United States
- CEO
- John Walter Hanna Jr.
- Employees
- 763
- Market cap
- $3.3 B
- IPO
- 17/07/2014
CareDx, Inc. is a global innovator in the healthcare sector specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their healthcare providers. The company's extensive portfolio features specialized diagnostic solutions for organ…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
CareDx stock: price history
1D
-4.0%
1W
+0.5%
1M
+19.5%
6M
+198.8%
YTD
+239.7%
1Y
+327.0%
2Y
+144.5%
5Y
-9.9%
10Y
+1,629.7%
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~53% stronger price swings than usual
CareDx stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
1 more assignment (Enabler/Second row) Pro-only.
CareDx is a specialized company in transplant medicine focused on developing and distributing diagnostic and management tools for organ recipients. The portfolio encompasses highly specialized tests for organ monitoring using dd-cfDNA technology as well as various HLA typing methods. In addition to diagnostic services, CareDx offers software platforms such as Ottr and XynQAPI for transplant management to optimize patient care and quality monitoring. Distribution occurs both directly and through a network of distributors.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- None
- Moat type
- None
- Capital intensity
- Medium
- Customer concentration
- Unknown
Suppliers & customers in our universe
Illumina, Inc.DescriptionAsk the agents about CareDx
Analyst assessment of CareDx
PRICE TARGET LOW
US$46.00
CONSENSUS
US$62.25
MEDIAN
US$64.50
PRICE TARGET HIGH
US$74.00
0
STRONG BUY
10
BUY
3
HOLD
0
SELL
0
STRONG SELL
13
TOTAL · Buy
As of: 24/09/2026
CareDx stock metrics
P/E
29.74
P/B
7.74
EV/EBITDA
190.04
RETURN ON EQUITY
26.0%
NET MARGIN
83.8%
DEBT/EQUITY
0.05
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
95.6%
FLOAT SHARES
49,455,330
AVG. DAILY VOLUME (30D)
1,397,345
Insider transactions (SEC)
Novack Jeffrey Adam
Meng Jessica
Goldberg Michael
Kennedy Keith
Hanna John Walter JR
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -4.0%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about CareDx stock
What does CareDx do?
CareDx, Inc is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is John Walter Hanna Jr., the company employs around 763 people.
The IPO was on 17/07/2014; the stock trades on NASDAQ under the ticker CDNA.
What do analysts say about CareDx stock?
13 analysts rate the stock, the consensus is Buy (as of 24/09/2026).
The average price target is US$62.25, ranging from US$46.00 to US$74.00, with a median of US$64.50.
This is an external assessment, not a statement by Market Jury.
When does CareDx report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 53% stronger than usual.
Does CareDx pay a dividend?
No, CareDx currently does not pay a dividend.
Which stocks are comparable to CareDx?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get CareDx stock analyzed?
Clicking "Analyze stock" lets five strategies assess CareDx against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.